AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21112875 — intervention group
Group type: EXPERIMENTAL
Intervention: JUMP-in programme
Number of subjects: 2848
Study 21112875 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 2848
Study 19232035 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide (up to 6 mg/day, 2 mg three times a day)
Number of subjects: 103
Study 19232035 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (up to 300 mg/day, 100 mg three times a day)
Number of subjects: 103
Study 19232035 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Acarbose vs Repaglinide
Number of subjects: 103
Study 17402796 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 1400
Study 17402796 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg weekly or every other week
Number of subjects: 1400
Study 14985268 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% l-menthol
Number of subjects: 10
Study 14985268 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (control)
Number of subjects: 10
Study 14985268 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% l-menthol during A fibre conduction blockade
Number of subjects: 10
Study 12405569 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 J rectilinear biphasic shocks
Number of subjects: 14
Study 12405569 — intervention group
Group type: COMPARATOR
Intervention: 150 J monophasic damped sine shocks
Number of subjects: 14
Study 9934380 — intervention group
Group type: EXPERIMENTAL
Intervention: Technically oriented style of care
Number of subjects: 509
Study 9934380 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice style emphasizing patient activation
Number of subjects: 509
Study 9934380 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower baseline patient health status
Number of subjects: 509
Study 9934380 — intervention group
Group type: EXPERIMENTAL
Intervention: Declined health status over the study period
Number of subjects: 509
Study 7752175 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg once daily
Number of subjects: 40
Study 7752175 — intervention group
Group type: COMPARATOR
Intervention: Nitrendipine 20 mg once daily
Number of subjects: 40
Study 2259980 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 43
Study 2259980 — intervention group
Group type: COMPARATOR
Intervention: Nonsealant (control)
Number of subjects: 43
Study 7353342 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-length cigarettes
Number of subjects: 10
Study 7353342 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-quarter-length cigarettes
Number of subjects: 10
Study 7353342 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-length cigarettes
Number of subjects: 10
Study 6849210 — intervention group
Group type: EXPERIMENTAL
Intervention: gentamicin plus metronidazole
Number of subjects: 128
Study 6849210 — intervention group
Group type: COMPARATOR
Intervention: gentamicin plus clindamycin
Number of subjects: 128
Study 29679398 — intervention group
Group type: EXPERIMENTAL
Intervention: QQ follow-up group (instant messaging software)
Number of subjects: 160
Study 29679398 — intervention group
Group type: COMPARATOR
Intervention: Traditional follow-up group
Number of subjects: 160
Study 27203284 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV vaccination awareness and education intervention
Number of subjects: 192
Study 27203284 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 192
Study 24971433 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) tapering after antithymocyte globulin (h-ATG) for 6 months, tapered over 18 months (total of 2 years)
Number of subjects: 102
Study 24971433 — intervention group
Group type: COMPARATOR
Intervention: Historical control group treated with h-ATG/CsA for 6 months, CsA discontinued at 6 months
Number of subjects: 102
Study 24971433 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) tapering after antithymocyte globulin (h-ATG)
Number of subjects: 102
Study 23257009 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinshuibao capsules (3 capsules three times a day for 2-3 courses of treatment, each course = 6 weeks)
Number of subjects: 270
Study 23257009 — intervention group
Group type: EXPERIMENTAL
Intervention: Jinshuibao capsules
Number of subjects: 270
Study 23257009 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 270
Study 20973950 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential intervention (phone call, SMS, postal reminder)
Number of subjects: 2123
Study 20973950 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 2123
Study 20973950 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction survey with reminders
Number of subjects: 2123
Study 20973950 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of intervention
Number of subjects: 2123
Study 18515690 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem solving therapy-primary care
Number of subjects: 306
Study 18515690 — intervention group
Group type: COMPARATOR
Intervention: Dietary education control
Number of subjects: 306
Study 16052083 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg TH9507
Number of subjects: 61
Study 16052083 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg TH9507
Number of subjects: 61
Study 16052083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 12771488 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol
Number of subjects: 20
Study 12771488 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacalcitol
Number of subjects: 20
Study 12771488 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 20
Study 12771488 — intervention group
Group type: COMPARATOR
Intervention: Petrolatum (placebo)
Number of subjects: 20
Study 10329288 — intervention group
Group type: EXPERIMENTAL
Intervention: Syllable repetition
Number of subjects: 13
Study 10329288 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonation
Number of subjects: 13
Study 10329288 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive lip closure
Number of subjects: 13
Study 10329288 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined tasks in a single session
Number of subjects: 13
Study 10329288 — intervention group
Group type: EXPERIMENTAL
Intervention: Separate scanning sessions for tasks
Number of subjects: 13
Study 8725496 — intervention group
Group type: EXPERIMENTAL
Intervention: High retroperitoneal ligation of the left spermatic vein
Number of subjects: 51
Study 8725496 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 51
Study 1776889 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to reduce stimulation
Number of subjects: 27
Study 1776889 — intervention group
Group type: COMPARATOR
Intervention: No advice (control)
Number of subjects: 27
Study 1776889 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to reduce stimulation for infants under 12 weeks
Number of subjects: 27
Study 1776889 — intervention group
Group type: COMPARATOR
Intervention: No advice for infants under 12 weeks (control)
Number of subjects: 27
Study 6292443 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium trisilicate
Number of subjects: 6
Study 6292443 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaolin
Number of subjects: 6
Study 30525953 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic mixture including Lactobacillus acidophilus GLA‐14 and Lactobacillus rhamnosus HN001 plus bovine lactoferrin
Number of subjects: 48
Study 30525953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 28409557 — intervention group
Group type: EXPERIMENTAL
Intervention: Silk garments (100% silk, DermaSilk or DreamSkin) worn for up to 6 months, supplied as three sets per participant.
Number of subjects: 300
Study 28409557 — intervention group
Group type: COMPARATOR
Intervention: Standard care (without silk garments).
Number of subjects: 300
Study 28409557 — intervention group
Group type: EXPERIMENTAL
Intervention: Silk garments (100% silk).
Number of subjects: 300
Study 25907003 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination (FDC) of solifenacin 6 mg plus TOCAS (0.4 mg)
Number of subjects: 0
Study 25907003 — intervention group
Group type: COMPARATOR
Intervention: TOCAS monotherapy (0.4 mg)
Number of subjects: 0
Study 25907003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 24919094 — intervention group
Group type: EXPERIMENTAL
Intervention: Royal jelly
Number of subjects: 103
Study 24919094 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine hydrochloride and nystatin rinses (Control)
Number of subjects: 103
Study 22411849 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (20,000 IU every 3 weeks, 40,000 IU every 3 weeks, and 40,000 IU every 2 weeks)
Number of subjects: 16
Study 22411849 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo)
Number of subjects: 16
Study 19073788 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental iron source (7.6 mg FeSO4 providing 0.9 mg 58Fe as FeSO4)
Number of subjects: 18
Study 19073788 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonheme food source (orange‐fleshed sweet potato: 1.4 mg native Fe)
Number of subjects: 18
Study 19073788 — intervention group
Group type: COMPARATOR
Intervention: Presence of food
Number of subjects: 18
Study 19073788 — intervention group
Group type: COMPARATOR
Intervention: Absence of food
Number of subjects: 18
Study 17093965 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam (7.5 mg) 15 min before MRI
Number of subjects: 72
Study 17093965 — intervention group
Group type: COMPARATOR
Intervention: Intranasal midazolam (1 or 2 mg via nasal spray) immediately prior to MRI
Number of subjects: 72
Study 15044206 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (250,000 IU) instilled over 4.5 ± 2 days
Number of subjects: 53
Study 15044206 — intervention group
Group type: COMPARATOR
Intervention: Normal saline instilled over 3 ± 1.3 days
Number of subjects: 53
Study 11811113 — intervention group
Group type: EXPERIMENTAL
Intervention: Allicor 600 mg/day
Number of subjects: 29
Study 11811113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 9611361 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask anaesthesia
Number of subjects: 0
Study 9611361 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation anaesthesia
Number of subjects: 0
Study 8147677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg/d
Number of subjects: 505
Study 8147677 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 12.5 mg/d
Number of subjects: 505
Study 8147677 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide 25 mg/d
Number of subjects: 505
Study 8147677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg/d + Hydrochlorothiazide 12.5 mg/d
Number of subjects: 505
Study 8147677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg/d + Hydrochlorothiazide 25 mg/d
Number of subjects: 505
Study 8147677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 505
Study 3145000 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 40
Study 3145000 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 40
Study 31823152 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223 (55 kBq/kg) plus abiraterone acetate 1000 mg once daily and prednisone/prednisolone 5 mg twice daily
Number of subjects: 114
Study 31823152 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus abiraterone acetate 1000 mg once daily and prednisone/prednisolone 5 mg twice daily
Number of subjects: 114
Study 30273821 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR)
Number of subjects: 220
Study 30273821 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum diet (AL)
Number of subjects: 220
Study 28744855 — intervention group
Group type: EXPERIMENTAL
Intervention: Active (stimulation on)
Number of subjects: 16
Study 28744855 — intervention group
Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 16
Study 26036333 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulator training
Number of subjects: 10
Study 26036333 — intervention group
Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 10
Study 23426454 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine
Number of subjects: 117
Study 23426454 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 23426454 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine+Bifidobacterium infantis 35624
Number of subjects: 117
Study 22177437 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (10,000 U/kg)
Number of subjects: 150
Study 22177437 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (3200 U/d)
Number of subjects: 150
Study 22177437 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 150
Study 19249105 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS with placebo
Number of subjects: 60
Study 19249105 — intervention group
Group type: COMPARATOR
Intervention: Venlafaxine ER with sham rTMS
Number of subjects: 60
Study 17130411 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 to 600 mg/day
Number of subjects: 137
Study 17130411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 15521804 — intervention group
Group type: EXPERIMENTAL
Intervention: Full report of the entire list
Number of subjects: 0
Study 15521804 — intervention group
Group type: EXPERIMENTAL
Intervention: Final word report
Number of subjects: 0
Study 15521804 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated words presented in sentences
Number of subjects: 0
Study 11305982 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (target heart rate 85% +/- 5 beats/min)
Number of subjects: 185
Study 11305982 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity exercise program (target heart rate 50% VO(2 max) +/- 5 beats/min)
Number of subjects: 185
Study 9328304 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 10-15 mg/kg/d
Number of subjects: 52
Study 8405741 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (7-36 amide) infusion at 1.2 pmol x kg‐1 x min‐1
Number of subjects: 10
Study 8405741 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study 3910836 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone 15 mg/day
Number of subjects: 20
Study 3910836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30962946 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-based hand rub (ABHR) provided to postpartum mothers, with instructions on use and training.
Number of subjects: 103
Study 30962946 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group) without ABHR.
Number of subjects: 103
Study 29089172 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrebreather mask with flush rate oxygen (40 to 60 L/min)
Number of subjects: 57
Study 29089172 — intervention group
Group type: COMPARATOR
Intervention: Bag-valve mask with flush rate oxygen (40 to 60 L/min)
Number of subjects: 57
Study 29089172 — intervention group
Group type: COMPARATOR
Intervention: Bag-valve mask with simulated mask leak
Number of subjects: 57
Study 29089172 — intervention group
Group type: COMPARATOR
Intervention: Bag-valve mask with inspiratory assistance
Number of subjects: 57
Study 25391264 — intervention group
Group type: EXPERIMENTAL
Intervention: Short lymphoscintigraphy protocol (0-2 mL of unfiltered technetium sulphur colloid injected the morning before surgery)
Number of subjects: 133
Study 25391264 — intervention group
Group type: EXPERIMENTAL
Intervention: Long lymphoscintigraphy protocol (0-2 mL of unfiltered technetium sulphur colloid injected the day before surgery)
Number of subjects: 133
Study 25391264 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined technetium/patent blue labeling technique
Number of subjects: 133
Study 25391264 — intervention group
Group type: COMPARATOR
Intervention: Both short and long lymphoscintigraphy protocols
Number of subjects: 133
Study 25391264 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoscintigraphy
Number of subjects: 133
Study 22890087 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric device
Number of subjects: 52
Study 22890087 — intervention group
Group type: COMPARATOR
Intervention: Rotatory instruments
Number of subjects: 52
Study 22890087 — intervention group
Group type: COMPARATOR
Intervention: Burr (rotatory instruments)
Number of subjects: 52
Study 22092476 — intervention group
Group type: EXPERIMENTAL
Intervention: OFD + rhGDF-5/β-TCP (n=10)
Number of subjects: 20
Study 22092476 — intervention group
Group type: COMPARATOR
Intervention: OFD alone (control; n=10)
Number of subjects: 20
Study 19651944 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard posterior cruciate-retaining total knee prosthesis
Number of subjects: 54
Study 19651944 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flexion posterior cruciate-retaining total knee prosthesis
Number of subjects: 54
Study 17334317 — intervention group
Group type: EXPERIMENTAL
Intervention: Active low-frequency rTMS
Number of subjects: 4
Study 17334317 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 4
Study 14987278 — intervention group
Group type: EXPERIMENTAL
Intervention: Local KUVA treatment
Number of subjects: 33
Study 14987278 — intervention group
Group type: COMPARATOR
Intervention: Systemic PUVA treatment
Number of subjects: 33
Study 11256551 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (nurse-run asthma education program)
Number of subjects: 28
Study 11256551 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 28
Study 7748631 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared care
Number of subjects: 554
Study 7748631 — intervention group
Group type: COMPARATOR
Intervention: Outpatient clinic follow-up
Number of subjects: 554
Study 7748631 — intervention group
Group type: COMPARATOR
Intervention: Nurse practitioner clinic
Number of subjects: 554
Study 7748631 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners' participation
Number of subjects: 554
Study 7748631 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient acceptability of shared care
Number of subjects: 554
Study 7748631 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient preference for follow-up method
Number of subjects: 554
Study 7748631 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness ranking
Number of subjects: 554
Study 3379743 — intervention group
Group type: EXPERIMENTAL
Intervention: Empirical regimen (4.8 million U of aqueous penicillin G procaine intramuscularly and 1.0 g of probenecid orally, followed by 100 mg of oral doxycycline twice daily for seven days)
Number of subjects: 129
Study 3379743 — intervention group
Group type: COMPARATOR
Intervention: Specific therapy for each infection as it was recognized
Number of subjects: 129
Study 31008797 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-ART IL-6
Number of subjects: 613
Study 31008797 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-ART TNFα
Number of subjects: 613
Study 31008797 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CRP
Number of subjects: 613
Study 31008797 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline IL-6
Number of subjects: 613
Study 31008797 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP, IL-6, soluble CD14, TNFα, HIV viral load (between weeks 0 and 4)
Number of subjects: 613
Study 28527549 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous acetaminophen
Number of subjects: 32
Study 28527549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 26083959 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-initiated brief intervention (BI)
Number of subjects: 267
Study 23291972 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic matrix (HM)
Number of subjects: 30
Study 23291972 — intervention group
Group type: COMPARATOR
Intervention: Electrosurgical bipolar coagulation (EBC)
Number of subjects: 30
Study 21915483 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor intervention (aerobic exercises including flexibility, strength, agility, and functional balance exercises) for 6 months, 60 minutes three times per week
Number of subjects: 32
Study 21915483 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor intervention (aerobic exercises)
Number of subjects: 32
Study 21915483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 19230469 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsitol‐Enabled Budesonide Inhalation Solution (CBIS) 120 microg twice daily
Number of subjects: 17
Study 19230469 — intervention group
Group type: COMPARATOR
Intervention: Pulmicort Respules (budesonide suspension) 500 microg twice daily
Number of subjects: 17
Study 17035697 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron (sodium ferric gluconate complex) 250 mg i.v. weekly x 4
Number of subjects: 75
Study 17035697 — intervention group
Group type: COMPARATOR
Intervention: Oral iron (ferrous sulfate) 325 mg t.i.d. x 42 days
Number of subjects: 75
Study 12832708 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic training programme (1 hour per week for approximately 20 sessions)
Number of subjects: 54
Study 12832708 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 54
Study 10616844 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 352
Study 10616844 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 352
Study 9228490 — intervention group
Group type: EXPERIMENTAL
Intervention: Childbirth preparation with the Lamaze method
Number of subjects: 47
Study 9228490 — intervention group
Group type: COMPARATOR
Intervention: No childbirth preparation
Number of subjects: 47
Study 9228490 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior during labor (regardless of group)
Number of subjects: 47
Study 7960018 — intervention group
Group type: EXPERIMENTAL
Intervention: 235T allele frequency in hypertensive group (83%)
Number of subjects: 187